Other Capital Market Information | 25 March 2019 12:36


Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

Fresenius Medical Care AG & Co. KGaA / Fresenius Medical Care AG & Co. KGaA
/ Announcement pursuant to Art. 5

25.03.2019 / 12:36
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------


- Share buy-back - 2nd Interim Report

In the period from March 18, 2019 until and including March 22, 2019, a
total of 734,693 shares were repurchased within the framework of the share
buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius
Medical Care') announced on March 11, 2019 pursuant to Art. 5 para. 1 lit.
a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated
Regulation (EU) 2016/1052.

The purchase was carried out exclusively by a credit institution
commissioned by Fresenius Medical Care via the XETRA trading platform on
the Frankfurt Stock Exchange:

Day of repurchase         Aggregated volume in      Weighted average share
                          number of shares          price
                                                    in EUR
18.03.2019                135,000                   69.7059
19.03.2019                140,000                   69.6201
20.03.2019                94,284                    71.0604
21.03.2019                149,878                   70.1986
22.03.2019                215,531                   69.2075

The total volume of shares repurchased within the framework of this share
buy-back in the period from March 12, 2019 until and including March 22,
2019 therefore amounts to 1,284,693 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of
Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical
Care's website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., March 25, 2019


---------------------------------------------------------------------------

25.03.2019 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de

---------------------------------------------------------------------------

     Language:    English
     Company:     Fresenius Medical Care AG & Co. KGaA
                  Else-Kröner-Straße 1
                  61352 Bad Homburg
                  Germany
     Internet:    www.freseniusmedicalcare.com



     End of News    DGAP News Service